Synthesis and Evaluation of New 1-Oxa-8-azaspiro[4.5]decane Derivatives As Candidate Radioligands for Sigma-1 Receptors

Jiale Tian,Yingfang He,Winnie Deuther-Conrad,Hualong Fu,Fang Xie,Ying Zhang,Tao Wang,Xiaojun Zhang,Jinming Zhang,Peter Brust,Yiyun Huang,Hongmei Jia
DOI: https://doi.org/10.1016/j.bmc.2020.115560
IF: 3.461
2020-01-01
Bioorganic & Medicinal Chemistry
Abstract:We report the design, synthesis, and evaluation of a series of 1-oxa-8-azaspiro[4.5]decane and 1,5-dioxa-9-azaspiro[5.5]undecane derivatives as selective sigma(1) receptor ligands. All seven ligands exhibited nanomolar affinity for sigma(1) receptors (K-i(sigma(1)) = 0.47 - 12.1 nM) and moderate selectivity over sigma(2) receptors (K-i(sigma(2))/K-i(sigma(1)) = 2 - 44). Compound 8, with the best selectivity among these ligands, was selected for radiolabeling and further evaluation. Radioligand [F-18]8 was prepared via nucleophilic F-18-substitution of the corresponding tosylate precursor, with an overall isolated radiochemical yield of 12-35%, a radiochemical purity of greater than 99%, and molar activity of 94 - 121 GBq/mu mol. Biodistribution studies of [F-18]8 in mice demonstrated high initial brain uptake at 2 min. Pretreatment with SA4503 resulted in significantly reduced brain-to-blood ratio (70% - 75% at 30 min). Ex vivo autoradiography in ICR mice demonstrated high accumulation of the radiotracer in sigma(1) receptor-rich brain areas. These findings suggest that [F-18]8 could be a lead compound for further structural modifications to develop potential brain imaging agents for sigma(1) receptors.
What problem does this paper attempt to address?